Deferoxamine mesylate
Deferoxamine Mesylate for Injection, USPRx only
Approved
Approval ID
6cedeb24-e7ba-2571-7737-d90da4e666ab
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 1, 2021
Manufacturers
FDA
Alvogen Inc.
DUNS: 008057330
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code47781-624
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateOctober 7, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 2 g in 1 1
Code: V9TKO7EO6K
Classification: ACTIB
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code47781-623
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateOctober 7, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 500 mg in 1 1
Code: V9TKO7EO6K
Classification: ACTIB